A prominent research firm, Cognizance Market Research added a cutting-edge industry report on “Radiopharmaceuticals Market”. The report studies the current as well as past growth trends and opportunities for the market to gain valuable insights during the forecast period from 2022 to 2030.
Radiopharmaceuticals Market Analysis
According to cognizance market research the radiopharmaceuticals market is anticipated to reach US$ 11,600.49 Million by the end of 2030 from US$ 5,125.25 Million in 2022, expanding at a CAGR of 10.8% over the forecast period that is 2023 to 2030.
What are Radiopharmaceuticals?
Radiopharmaceuticals are radioactive drugs (radioisotopes) used in the prevention or treatment of cancer. These drugs can be administered orally (as pills), intravenously (by injection into a patient’s vein), or intramuscularly (inserted into a cavity in the body). Despite the fact that nuclear medicine specialists are required to provide the medications, radiopharmacology is nonetheless regulated as a subspecialty of radiation therapy. Every radiopharmaceutical is intended to go to a certain location within the body. It will discharge radioactive substances after it has reached its target, which will kill the tumour cells. Thyroid cancer, brain cancer, lymphoma, and tumours that have migrated to the bones are among the cancers that radiopharmaceuticals can currently target, according to study. Because oncologists can monitor radioactivity in the body after the medications are taken to check for cancer, radiopharmaceuticals can also be used to diagnose some cancers. A gamma camera or some comparable gamma imaging device must be used for this, as it calls for a specialised imaging system. Radiopharmaceuticals are referred to as “tracers” when they are utilised for diagnostic reasons. Radiation levels in diagnostic radiopharmaceuticals are lower than in therapeutic radiopharmaceuticals.
Radiopharmaceuticals Market Outlook
The radiopharmaceutical market is expected to be primarily driven by increasing radio-therapeutic penetration. The use of radiopharmaceuticals in the diagnosis and treatment of a wide range of illnesses, such as cancer, cardiovascular disease, and neurological issues, is growing quickly. Radiopharmaceuticals are often utilised in the treatment of a number of disorders because of the features of radioactive decay and the potential for focused therapeutic irradiation. The rare COVID-19 epidemic, however, restrained market growth.
Worldwide manufacture of radioisotopes has ended, as have research efforts. The demand and supply chains were disrupted, which led to a decrease in the value of the global market. The market will develop significantly as a result of the quick adoption of advanced nuclear imaging technologies like SPECT and Positron Emission Tomography (PET). Increased research and development from key players is assisting the market expansion of radiopharmaceuticals.
The radiopharmaceuticals market has been segmented into type, application, and geography. Based on type the Radiopharmaceuticals market is segmented into diagnostic and therapeutic.
On the basis of application, radiopharmaceuticals market is segmented into neurology, cardiology, oncology and others.
On the basis of end user, radiopharmaceuticals market is segmented into Hospitals, Ambulatory Surgical Centres, Diagnostic Centres, Cancer Research Institutes and Others.
North America, Europe, Asia-Pacific, and the rest of the world are covered in the study’s market insights by region. The market is anticipated to expand as a result of the region’s rapid adoption of efficient nuclear imaging technologies as well as the growing use of technically complex and cutting-edge therapeutic radiopharmaceuticals. Also, it is projected that during the projection period, there will be an increase in the prevalence of various cancers as well as other chronic illnesses, which will support market growth in North America.
The report offers the revenue of the Radiopharmaceuticals market for the period 2020-2030, considering 2020 & 2021 as a historical year, 2022 as the base year and 2023 to 2030 as the forecast year. The report also provides the compound annual growth rate (CAGR) for the Radiopharmaceuticals market for the forecast period. The Radiopharmaceuticals market report provides insights and in-depth analysis into developments impacting enterprises and businesses on a regional and global level. The report covers the Radiopharmaceuticals market performance in terms of revenue contribution from several segments and comprises a detailed analysis of key drivers, trends, restraints, and opportunities prompting revenue growth of the Radiopharmaceuticals market.
The report has been prepared after wide-ranging secondary and primary research. Secondary research included internet sources, numerical data from government organizations, trade associations, and websites. Analysts have also employed an amalgamation of bottom-up and top-down approaches to study numerous phenomena in the Radiopharmaceuticals market. Secondary research involved a detailed analysis of significant players’ product portfolio. Literature review, press releases, annual reports, white paper, and relevant documents have been also studied to understand the Radiopharmaceuticals market. Primary research involved a great extent of research efforts, wherein experts carried out interviews telephonic as well as questioner-based with industry experts and opinion-makers.
The report includes an executive summary, along with a growth pattern of different segmented included in the scope of the study. The Y-o-Y analysis with elaborate market insights has been provided in the report to comprehend the Y-o-Y trends in the Radiopharmaceuticals market. Additionally, the report focuses on altering competitive dynamics in the global market. These indices serve as valued tools for present market players as well as for companies interested in participating in the Radiopharmaceuticals market. The subsequent section of the Radiopharmaceuticals report highlights the USPs, which include key industry events (Type launch, research partnership, acquisition, etc.), technology advancements, pipeline analysis, prevalence data, and regulatory scenario.
Radiopharmaceuticals Market Competitive Landscape
The “Radiopharmaceuticals Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as:
The report explores the competitive scenario of the Radiopharmaceuticals market. Major players operating in the Radiopharmaceuticals market have been identified and profiled for unique commercial attributes. Company overview (company description, Type portfolio, geographic presence, employee strength, Key management, etc.), financials, SWOT analysis, recent developments, and key strategies are some of the features of companies profiled in the Radiopharmaceuticals market report.
Radiopharmaceuticals Market, by Product Type
Radiopharmaceuticals Market, by Application
Radiopharmaceuticals Market, by End user
Radiopharmaceuticals Market, by Region
Radiopharmaceuticals are radioactive drugs that are used to diagnose and treat diseases. They are made by attaching radioactive isotopes to molecules that can target specific organs or tissues in the body. Radiopharmaceuticals can be administered orally, intravenously, or intramuscularly.
Radiopharmaceuticals can be classified into two main types: diagnostic and therapeutic.
Radiopharmaceuticals work by binding to specific targets in the body and emitting radiation. This radiation can be used to image organs and tissues, or it can be used to kill cancer cells.
Radiopharmaceuticals offer several benefits over traditional treatments, such as chemotherapy and radiation therapy. They are often more targeted and effective, and they generally have fewer side effects.
The future outlook for the radiopharmaceuticals market is positive. The market is expected to grow rapidly in the coming years, driven by factors such as the increasing prevalence of cancer, the rising demand for targeted therapies, and the development of new radiopharmaceutical treatments for a wider range of diseases.
Get insights that lead to new growth opportunities
We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports
We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail